Yisheng Biopharma Co Ltd (Yisheng Biopharma), a Chinese biopharmaceutical company, has chosen Cambodia as the first country to expand its business and product sales operations in Southeast Asia with the launch of two subsidiaries here yesterday.
“The opening of these two divisions, Anderson Biotech Company Limited and Royal OncoCare Hospitality, is an important milestone in the company’s history.
“Our product, Yivyka, is approved in Cambodia for the treatment of advanced solid tumours including lung, breast, liver, colorectal and stomach cancers,” said Zhang Yi, founder and chairman of Yisheng Biopharma.
